Clinical trial
Myopia Progression and the Effect of 7-Methylxanthine
NCT00263471 · Trier Research Laboratories, Other · Unknown status
Key facts
| NCT number | NCT00263471 |
|---|---|
| Title | Myopia Progression and the Effect of 7-Methylxanthine |
| Official title | Phase 2 Study of the Effect of 7-Methylxanthine on the Progression of Childhood Myopia |
| Lead sponsor | Trier Research Laboratories, Other |
| Collaborators | Generalkonsul Einar Høyvalds Fond Jørgen Bagenkop Nielsens Myopi-Fond Chr. Andersen og hustru Ingeborg Andersen, f. Schmidts legat (fond) oprettet af deres datter, frk. Lilli Ellen Andersen. |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myopia |
| Intervention type | Drug |
| Interventions | 7-methylxanthine |
| Enrollment | 90 |
| Start date | Oct 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Dec 8, 2005 |
| Last update posted | Dec 14, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: